Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIA Melanoma”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00035165
What this trial is testing

EPO906 Therapy in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 51
Testing effectiveness (Phase 2)Ended earlyNCT02052193
What this trial is testing

Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study

Who this might be right for
Metastatic Melanoma (Carrying BRAF V600 Mutation)
University Hospital Tuebingen 8
Early research (Phase 1)Active Not RecruitingNCT04875728
What this trial is testing

The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8+11 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00306566
What this trial is testing

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG
Testing effectiveness (Phase 2)Study completedNCT00669019
What this trial is testing

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT01341158
What this trial is testing

NAM-Trial: Multiferon in Malignant Melanoma

Who this might be right for
Locoregional Metastases in Malignant Melanoma Stages IIIB/C
University Hospital Tuebingen 42
Not applicableActive Not RecruitingNCT03677739
What this trial is testing

Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+19 more
Rutgers, The State University of New Jersey 1,160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05275374
What this trial is testing

XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation

Who this might be right for
CancerBRAF V600 MutationMelanoma+3 more
Xynomic Pharmaceuticals, Inc. 221
Not applicableStudy completedNCT00897546
What this trial is testing

Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,716
Testing effectiveness (Phase 2)Looking for participantsNCT05251389
What this trial is testing

FMT to Convert Response to Immunotherapy

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Testing effectiveness (Phase 2)Looking for participantsNCT06305247
What this trial is testing

Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
Ipsen 220
Testing effectiveness (Phase 2)Looking for participantsNCT06214156
What this trial is testing

A Clinical Study of T3011 in Subjects With Advanced Melanoma

Who this might be right for
Advanced Melanoma
Shanghai Pharmaceuticals Holding Co., Ltd 42
Not applicableLooking for participantsNCT07259304
What this trial is testing

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more
University of Southern California 250
Testing effectiveness (Phase 2)Study completedNCT04168528
What this trial is testing

Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

Who this might be right for
Malignant Solid TumorBreast CancerMelanoma (Skin)
Universitair Ziekenhuis Brussel 13
Large-scale testing (Phase 3)Active Not RecruitingNCT04309409
What this trial is testing

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

Who this might be right for
Malignant Melanoma Stage II
University Hospital, Essen 374
Testing effectiveness (Phase 2)Ended earlyNCT03997474
What this trial is testing

ATL001 in Patients With Metastatic or Recurrent Melanoma

Who this might be right for
Melanoma
Achilles Therapeutics UK Limited 13
Testing effectiveness (Phase 2)Study completedNCT02301611
What this trial is testing

Phase IIB TL + YCWP + DC in Melanoma

Who this might be right for
Melanoma
Elios Therapeutics, LLC 187
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586
What this trial is testing

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 210
Large-scale testing (Phase 3)Study completedNCT00204529
What this trial is testing

Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB

Who this might be right for
Melanoma
University Hospital Tuebingen 901
Load More Results